BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Rethinking Clinical Trials - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://rethinkingclinicaltrials.org
X-WR-CALDESC:Events for Rethinking Clinical Trials
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220708T130000
DTEND;TZID=America/New_York:20220708T140000
DTSTAMP:20260509T150236
CREATED:20220627T171747Z
LAST-MODIFIED:20220713T150350Z
UID:27474-1657285200-1657288800@rethinkingclinicaltrials.org
SUMMARY:Grand Rounds July 8: Results From the COVID-OUT Trial\, a Phase-3 Trial of Outpatient Treatment for COVID-19 Using Metformin\, Ivermectin\, and Fluvoxamine (Carolyn Bramante\, MD\, MPH; Thomas Murray\, PhD; Jaren Huling\, PhD)
DESCRIPTION:Speakers: \nCarolyn Bramante\, MD\, MPH\nAssistant Professor\, General Internal Medicine and Pediatrics\nCore Faculty\, Center for Pediatric Obesity Medicine\nCore Faculty\, Program for Health Disparities Research\nUniversity of Minnesota Medical School \nThomas Murray\, PhD\nAssistant Professor of Biostatistics\nDivision of Biostatistics\nUniversity of Minnesota School of Public Health \nJared Huling\, PhD\nAssistant Professor of Biostatistics\nDivision of Biostatistics\nUniversity of Minnesota School of Public Health \n  \nTopic: Results From the COVID-OUT Trial\, a Phase-3 trial of Outpatient Treatment for Covid-19 Using Metformin\, Ivermectin\, and Fluvoxamine\nDate: Friday\, July 8\, 2022\, 1:00-2:00 p.m. ET \n  \nJoin Zoom Meeting \nhttps://duke.zoom.us/j/95781921415?pwd=QlllTVd3Z0Q1S3BWT21sSjRpQ3p5Zz09 \nMeeting ID: 957 8192 1415 \nPasscode: 12345 \nClick ‘Connect to Audio”\nChoose ‘Computer Audio’ or ‘I will call in’.\nIf using the ‘call in option’\, follow the information from the dialog box that appears.\nBe certain to use the Access Code AND the Attendee ID. \nFor Audio ONLY:\nCall-in toll number (US/Canada): 1-650-479-3207\nAccess code: 2622 682 0537 \nNOTE: For Toll-free users\, the call-back (call me) services are also available.
URL:https://rethinkingclinicaltrials.org/event/grand-rounds-july-8-results-from-the-covid-out-trial-a-phase-3-trial-of-outpatient-treatment-for-covid-19-using-metformin-ivermectin-and-fluvoxamine/
CATEGORIES:Grand Rounds Event
END:VEVENT
END:VCALENDAR